498548-15-5

Basic information

• Product Name: 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5-hydroxy-3,7-bis(phenylmethoxy)-
• CAS NO: 498548-15-5
• Molecular Formula: C29H22O7
• Molecular Weight: 482.489
• Mol File: 498548-15-5.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5-hydroxy-3,7-bis(phenylmethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5-hydroxy-3,7-bis(phenylmethoxy)-(498548-15-5)
• EPA Substance Registry System: 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5-hydroxy-3,7-bis(phenylmethoxy)-(498548-15-5)

Safety Data

• Hazardous Substances Data: 498548-15-5(Hazardous Substances Data)

Upstream product

• 117-39-5 quercetol 
• 100-44-7 benzyl chloride 
• 357194-03-7 2-(2,2-diphenylbenzo[1,3]dioxol-5-yl)-3,5,7-trihydroxychromen-4-one 
• 498548-14-4 2-(2,2-diphenylbenzo[1,3]dioxol-5-yl)-3,5,7-tribenzyloxy-4H-chromen-4-one 

Downstream Products

• 1313191-84-2 2-(4-(2,3,4,6-tetra-O-acetyl)-β-D-glucopyranosyloxy-3-benzyloxyphenyl)-3,5,7-tribenzyloxy-4H-chromen-4-one 
• 1313191-85-3 2-(4-O-β-D-glucopyranosyloxy-3-benzyloxyphenyl)-3,5,7-tribenzyloxy-4H-chromen-4-one 
• 20229-56-5 spiraeoside 
• 1313191-83-1 C₄₃H₄₀O₁₆ 
• 1610737-61-5 3,7-bis(benzyloxy)-2-(4-((4-fluorobenzyl)oxy)-3-hydroxyphenyl)-5-hydroxy-4H-chromen-4-one 
• 1610737-79-5 2-(4-((4-fluorobenzyl)oxy)-3-hydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one 
• 498548-16-6 3,7-bis(benzyloxy)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-chromen-4-one 
• 3306-17-0 3,7-bis-benzyloxy-2-(3,4-dimethoxy-phenyl)-5-hydroxy-chromen-4-one 
• 3306-18-1 3,7-bis-benzyloxy-2-(3,4-dimethoxy-phenyl)-5-methoxy-chromen-4-one 
• 603-61-2 tamarixetin 

Relevant articles and documents

QUERCETIN DERIVATIVE, PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING THE SAME, AND METHOD FOR SYNTHESIZING THE SAME

The present invention relates to a novel quercetin derivative in which a 4′-hydroxy group of quercetin is substituted and which has excellent stability, to a pharmaceutical composition for preventing or treating cancer comprising the same, and to a synthe

Regiospecific synthesis of three quercetin O-β-glucosides of N-acetylglucosamine

The regiospecific synthesis of three quercetin O-β-glucosides of N-acetylglucosamine has been achieved in good yield. Selective di- and tri-O-benzylation of quercetin followed by O-glycosylation with 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-α-d-glucopyranosyl chloride under phase-transfer catalysis conditions yielded, after deacetylation and debenzylation, 3-, 3′- and 4′-glycosylated quercetin.

Design and discovery of flavonoid-based HIV-1 integrase inhibitors targeting both the active site and the interaction with LEDGF/p75

HIV integrase (IN) is an essential enzyme for the viral replication. Currently, three IN inhibitors have been approved for treating HIV-1 infection. All three drugs selectively inhibit the strand transfer reaction by chelating a divalent metal ion in the